Skip to main content

Table 2 Trial visits and documented parameters

From: Conventional partial pancreatoduodenectomy versus an extended pancreatoduodenectomy (triangle operation) for pancreatic head cancers—study protocol for the randomised controlled TRIANGLE trial

Visit

1

2

3–4a

5

6

7–12

Time point

Screening

Day of surgery, pathology

POD 5

POD 10–12

Day of discharge

POD 90

POM 6, 12, 18, 24, 30, 36 (or pre-mature trial termination)

Type of visit

Inpatient

Inpatient

Inpatient

Inpatient

Outpatient (inpatient) (telephone)

Outpatient (telephone)

 Written informed consent

X

     

 Preoperative inclusion/exclusion criteria

X

     

 Intraoperative inclusion criteria

 

X

    

 Demographics and baseline data

X

     

 Medical history

X

     

 Surgery data

 

X

    

 Randomisation

 

X

    

Primary endpoint

 Disease-free survival

  

X

X

X

X

Secondary endpoints

 Pathologic data

 

X

    

 Postoperative morbidity

  

X

X

X

 

 Length of hospital stay

   

X

  

 Overall survival

  

X

X

X

X

 Local recurrence

  

X

X

X

X

Patient-reported outcomes (PRO)

 Quality of recoveryc

X

 

(X)d

   

 Quality of life assessmentb

X

  

X

 

X

Safety

 SAE

 

X

X

X

X

X

  1. POD Postoperative day, POM Postoperative month, PRO Patient-reported outcome, SAE Serious adverse events
  2. aSkip respective visits if the patient has been discharged prior to visit
  3. bAccording to EORTC QLQ-C30 and -PAN26
  4. cAccording to the QoR-15
  5. dOnly on POD 5